This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nattakom, T. V. Articles by Wilmore, D. W. Search for Related Content PubMed PubMed Citation Articles by Nattakom, T. V. Articles by Wilmore, D. W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Bone Marrow Transplantation Social Bookmarking                         What's this?

Use of Vitamin E and Glutamine in the Successful Treatment of Severe Veno-Occlusive Disease Following Bone Marrow Transplantation

Department of Nutrition and Surgical Metabolism, Brigham and Women's Hospital, Harvard Medical School

Angela Charlton, RD

Dana Farber Cancer Institute, Boston

Douglas W. Wilmore, MD

Department of Nutrition and Surgical Metabolism, Brigham and Women's Hospital, Harvard Medical School

Veno-occlusive disease of the liver is a common complication following the administration of conditioning regimens to patients undergoing bone marrow transplantation. Free-radical damage to the liver is believed to be the cause of the hepatic outflow occlusion, and maintenance of adequate antioxidant stores of glutathione and vitamin E may be a means of counteracting the hepatotoxicity. We report the case of a 44-year-old woman who developed severe veno-occlusive disease after bone marrow transplantation and was treated with vitamin E, the major antioxidant of the cell membrane, and glutamine, a precursor of glutathione. The administration of this therapy was associated with reversal of the clinical and biochemical signs of severe hepatic dysfunction.

Nutrition in Clinical Practice, Vol. 10, No. 1, 16-18 (1995)
DOI: 10.1177/011542659501000116


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Kumar, L. D. DeLeve, P. S. Kamath, and A. Tefferi Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation Mayo Clin. Proc., May 1, 2003; 78(5): 589 - 598. [Abstract] [PDF]

				C. Duggan, J. Gannon, and W A. Walker Protective nutrients and functional foods for the gastrointestinal tract Am. J. Clinical Nutrition, May 1, 2002; 75(5): 789 - 808. [Abstract] [Full Text] [PDF]

				T. R. Ziegler Glutamine Supplementation in Cancer Patients Receiving Bone Marrow Transplantation and High Dose Chemotherapy J. Nutr., September 1, 2001; 131(9): 2578S - 2584. [Abstract] [Full Text] [PDF]

				C. R Jonas, A. B Puckett, D. P Jones, D. P Griffith, E. E Szeszycki, G. F Bergman, C. E Furr, C. Tyre, J. L Carlson, J. R Galloway, et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients Am. J. Clinical Nutrition, July 1, 2000; 72(1): 181 - 189. [Abstract] [Full Text] [PDF]

				T. W. Mattox Specialized Nutrition Management of Patients Receiving Hematopoietic Stem Cell Transplantation Nutr Clin Pract, February 1, 1999; 14(1): 5 - 15. [Abstract] [PDF]